Canadian Warrants

Quick Links:
Back to Home Page              Back to Warrant Sheets             Back to Expired Warrants

Address: 400 - 155 108th Ave NE
Bellevue WA United States 98004
Phone: 416 360 6390
Web Site: http://www.trilogy-international.com
 
Warrant Symbol - TRL.WT
Number  Trading - 89621T 11 6
Expiration Date - February 7, 2022
Cusip - 89621T 11 6
Exercise Price - $11.50

Warrants called to trade news:




Trilogy Int'l loses $40.6M (U.S.) from 2016 cont. ops

2017-03-27 08:11 MT - News Release

On Feb. 7, 2017, Alignvest Acquisition (AQX), a special purpose acquisition corporation listed on the Toronto Stock Exchange, and Trilogy International Partners LLC completed a transaction in which AQX invested $199.3-million in Trilogy LLC. At the same time, certain minority shareholders of 2degrees exchanged their 2degrees stock for AQX shares. As a result of these transactions, AQX acquired a 53-per-cent equity stake in Trilogy LLC. AQX has been renamed Trilogy International Partners. Its common shares trade on the Toronto Stock Exchange under the ticker TRL and its warrants trade on the exchange under the ticker TRL.WT.

Alignvest name change to Trilogy International

2017-02-07 12:52 MT - Change Name

The Toronto Stock Exchange reports that Alignvest Acquisition Corp. has completed its qualifying acquisition of Trilogy International Partners LLC as well as an offering of $81.4-million worth of unlisted Class B shares for $10 per share.

According to the TSX, as a result of the acquisition, each Class A share of Alignvest will be automatically converted into one share of the resulting company, Trilogy International Partners Inc., and each Alignvest warrant will be converted into one warrant of Trilogy. The Trilogy securities will begin trading at the open on Feb. 9, 2017, and the Alignvest securities will be delisted on the same day. The TSX reports that there will be 44,177,149 shares and 13,402,688 warrants of Trilogy issued and outstanding, with 52,737,605 Trilogy shares reserved for issuance. The Trilogy shares will trade under the symbol TRL and Cusip No. 89621T 10 8, while the Trilogy warrants will trade under the symbol TRL.WT and Cusip No. 89621T 11 6.

According to the TSX, the Trilogy warrants will be exercisable at $11.50 per share starting 30 days following the closing of the qualifying acquisition. The warrants will expire at 5 p.m. on Feb. 7, 2022.

For more information, see Alignvest's prospectus dated Dec. 20, 2016, its notice of special meeting of shareholders and management information circular dated Dec. 22, 2016, and its amendment to the circular dated Jan. 12, 2017. All documents are available on SEDAR.

© 2017 Canjex Publishing Ltd. All rights reserved.